Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas-Reference-Cited by-同舟云学术

Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas

Published:2012-05-17 Issue:23 Volume:118 Page:5840-5847
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Paik Paul K.,Johnson Melissa L.,D'Angelo Sandra P.,Sima Camelia S.,Ang Daphne,Dogan Snjezana,Miller Vincent A.,Ladanyi Marc,Kris Mark G.,Riely Gregory J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27637/fullpdf

Reference28 articles.

1. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA.,2003

2. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med.,2005

3. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer);Thatcher;Lancet.,2005

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med.,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science.,2004

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in India;ecancermedicalscience;2024-02-22

2. An Updated Review on KRAS Mutation in Lung Cancer (NSCLC) and Its Effects on Human Health;Applied Biochemistry and Biotechnology;2023-10-28

3. Adverse Side Effects of Crizotinib in the Treatment of Anaplastic Lymphoma Kinase-Mutated Non-small Cell Lung Cancer: A Systematic Review;Cureus;2023-09-19

4. A Functional Genomics Review of Non-Small-Cell Lung Cancer in Never Smokers;International Journal of Molecular Sciences;2023-08-28

5. The quantum leap in therapeutics for advanced ALK+ non-small cell lung cancer and pursuit to cure with precision medicine;Frontiers in Oncology;2022-08-08